Negative control region at the 5' end of murine leukemia virus long terminal repeats.
about
Evidence for physical interaction between the zinc-finger transcription factors YY1 and Sp1Transposable elements in the mammalian embryo: pioneers surviving through stealth and serviceRetroviral transcriptional regulation and embryonic stem cells: war and peaceOrigins of enhancer sequences of recombinant murine leukemia viruses from spontaneous B- and T-cell lymphomas of CWD mice.Structures of endogenous nonecotropic murine leukemia virus (MLV) long terminal repeats in wild mice: implication for evolution of MLVsVariable expression of Cre recombinase transgenes precludes reliable prediction of tissue-specific gene disruption by tail-biopsy genotypingLentivirus vector gene expression during ES cell-derived hematopoietic development in vitroSilencing of gene expression: implications for design of retrovirus vectors.Lysine methyltransferase G9a is required for de novo DNA methylation and the establishment, but not the maintenance, of proviral silencingOrigins of the endogenous and infectious laboratory mouse gammaretroviruses.The Moloney murine leukemia virus repressor binding site represses expression in murine and human hematopoietic stem cellsMultiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells.Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells.Primer binding site-dependent restriction of murine leukemia virus requires HP1 binding by TRIM28.Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells.Stable gammaretroviral vector expression during embryonic stem cell-derived in vitro hematopoietic development.The R-U5-5' leader sequence of neurovirulent wild mouse retrovirus contains an element controlling the incubation period of neurodegenerative diseaseHost restriction factors blocking retroviral replicationNegative regulation in correct tissue-specific expression of mouse mammary tumor virus in transgenic miceRegions of the Moloney murine leukemia virus genome specifically related to induction of promonocytic tumorsAlignment of U3 region sequences of mammalian type C viruses: identification of highly conserved motifs and implications for enhancer designSequence analysis of amphotropic and 10A1 murine leukemia viruses: close relationship to mink cell focus-inducing virusesDNA-binding proteins that interact with the long terminal repeat of radiation leukemia virusRelative importance of elements within the SL3-3 virus enhancer for T-cell specificityCloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virusDevelopment of a retroviral vector for inducible expression of transforming growth factor beta 1.The intracisternal A-particle upstream element interacts with transcription factor YY1 to activate transcription: pleiotropic effects of YY1 on distinct DNA promoter elements.Endogenous gammaretrovirus acquisition in Mus musculus subspecies carrying functional variants of the XPR1 virus receptorNegative regulation of the major histocompatibility complex class I promoter in embryonal carcinoma cells.Transcriptional Silencing of Moloney Murine Leukemia Virus in Human Embryonic Carcinoma Cells.EBP1, a novel host factor involved in primer binding site-dependent restriction of moloney murine leukemia virus in embryonic cells.Gene therapy: current status and future directions.Alpharetroviral vectors: from a cancer-causing agent to a useful tool for human gene therapy.The long terminal repeat negative control region is a critical element for insertional oncogenesis after gene transfer into hematopoietic progenitors with Moloney murine leukemia viral vectors.Exchange of viral promoter/enhancer elements with heterologous regulatory sequences generates targeted hybrid long terminal repeat vectors for gene therapy of melanoma.Amelioration of retroviral vector silencing in locus control region beta-globin-transgenic mice and transduced F9 embryonic cells.Recombinant Origins of Pathogenic and Nonpathogenic Mouse Gammaretroviruses with Polytropic Host Range.Enhancer functions in U3 of Akv virus: a role for cooperativity of a tandem repeat unit and its flanking DNA sequences.The transcription factor YY1 binds to negative regulatory elements in the human cytomegalovirus major immediate early enhancer/promoter and mediates repression in non-permissive cells.The 21bp repeat element of the human cytomegalovirus major immediate early enhancer is a negative regulator of gene expression in undifferentiated cells.
P2860
Q24562189-D11E5D25-EDDB-408E-9C5C-0EEAD1F45928Q26751043-9888D62F-051F-46C8-9E10-CD6B6831D180Q26865715-810D828D-9245-47B4-A700-4A1C5736790FQ30452120-0BC94DF1-6947-4158-A579-B1BBBC4161AFQ30628658-65DA1E38-80A8-4A55-BC4A-AA02033908BEQ33302112-94C18605-7875-4ECE-86F8-D665887535D4Q33787358-2A8E9A34-28F5-4718-8B2C-11A405E49200Q34323213-ECA6B74A-07E5-4977-B3B1-2A9AB72F12F2Q34804800-9F3FF2DA-9ED9-464F-B8B6-0CDFD6BDDBCDQ35014898-85DC3AC8-86D5-4F95-830E-A36881157272Q35803189-A7DB7224-B3A6-454A-AE3B-439E9EEDB953Q35831286-2296F6C7-F630-44D7-BA81-C6D53FFF3E2DQ36288334-C3634FBF-1F6F-4480-9BFF-A9DFBEE0FB20Q36540170-90B982A9-21CA-4961-9B37-C79FD39B81EBQ36548952-8B5198CA-0563-4C36-B8C8-E0BDB69748A0Q36665437-8E571DBD-82F3-4631-9266-D21595209375Q36683978-5AD708F5-E36A-4716-AB3C-154518926DDAQ36687748-846AFF92-E962-4B06-91E4-7E55AC9009AAQ36732618-5820F6F1-3F66-4EBD-B516-7D70DD4691A1Q36798682-5A130770-2672-4C65-8A07-2889747EC356Q36800277-D74EEA2E-2A1B-449C-9FE9-5CA12AA800E7Q36800996-4B65587A-53F2-43F3-88CA-4FD49BB1C176Q36803367-DFC0AECD-09BE-476A-AC50-2F01705C1270Q36804010-0074E3AF-4989-48BE-9214-A0AB54C96CF9Q36807628-10D6C0F1-6BF6-4755-938F-2F903FB99D81Q36811215-1ED254CD-0287-4FAF-8F36-976AA019DC9FQ36824673-6562FDB1-88EE-4E94-8E5F-4BE0CE273AE2Q37123479-C64BF437-8003-4E25-9F24-CE9D12D41B2BQ37478408-2031F86D-E213-4818-84BD-D422D8197582Q37512799-E988ACB4-BF9E-4D0A-ACAA-CCD57E68E840Q37547250-04CF89D9-E5B1-4615-AFDC-9F015708974DQ37942103-59D83F45-3EB1-4423-9F06-3190B5097078Q38285765-7A87FF98-D5EC-4ADD-907E-EA65CCB7C53DQ39528450-E26456E1-13EA-451B-90B8-88FFA283FAE3Q39577483-09CC8F79-90E4-478A-A095-6082612AC631Q39594565-75AC25AF-00A5-4A6E-A272-608AA249A0A2Q40088729-668A1B50-E7BC-4AF1-B66B-4C788451EBCBQ40109552-FBC1B273-99DE-4E47-AF46-D5B802279E69Q40400361-622D6C2D-166C-4391-887F-E2DF6E8FAC79Q40503318-4939D5BE-148E-4598-8D32-75D9BB7E0618
P2860
Negative control region at the 5' end of murine leukemia virus long terminal repeats.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Negative control region at the 5' end of murine leukemia virus long terminal repeats.
@ast
Negative control region at the 5' end of murine leukemia virus long terminal repeats.
@en
type
label
Negative control region at the 5' end of murine leukemia virus long terminal repeats.
@ast
Negative control region at the 5' end of murine leukemia virus long terminal repeats.
@en
prefLabel
Negative control region at the 5' end of murine leukemia virus long terminal repeats.
@ast
Negative control region at the 5' end of murine leukemia virus long terminal repeats.
@en
P2093
P2860
P356
P1476
Negative control region at the 5' end of murine leukemia virus long terminal repeats.
@en
P2093
P2860
P304
P356
10.1128/MCB.9.2.739
P407
P577
1989-02-01T00:00:00Z